GlaxoSmithKline's Duchenne MD drug mirrors placebo effect in PhIII
   looking almost identical in each case with a placebo.
   decline in walking distance, just as the placebo arm did. The decline
   Phase II. Using the North Star Ambulatory Assessment test, the placebo
   identical--a 0.12 decline in the placebo arm and a 0.14 decline in the